16798 Federal Register / Vol. 72, No.
65 / Thursday, April 5, 2007 / Notices
and pre-registration is encouraged (see
below).
SUPPLEMENTARY INFORMATION: Under the
authority of 42 U.S.C. Section 217a,
Section 222 of the Public Health Service
Act, as amended, and 42 CFR 121.12
(2000), ACOT was established to assist
the Secretary in enhancing organ
donation, ensuring that the system of
organ transplantation is grounded in the
best available medical science, and
assuring the public that the system is as
effective and equitable as possible, and,
thereby, increasing public confidence in
the integrity and effectiveness of the
transplantation system. ACOT is
composed of up to 25 members,
including the Chair. Members are
serving as Special Government
Employees and have diverse
backgrounds in fields such as organ
donation, health care public policy,
transplantation medicine and surgery,
critical care medicine and other medical
specialties involved in the identification
and referral of donors, non-physician
transplant professions, nursing,
epidemiology, immunology, law and
bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.
ACOT will hear presentations on
paired exchanges; the activities of the
Scientific Registry of Transplant
Recipients; a transplantation cost-
benefit study; transplant tourism; end-
of-life care and donation after cardiac
death (DCD) recovery; and a kidney
application policy that is under
development.
The draft meeting agenda will be
available on May 1 on the Department’s
donation Web site at http://
www.organdonor.gov/acot.html.
A registration form will be available
on April 15 on the Department’s
donation Web site at http://
www.organdonor.gov/acot.html. The
completed registration form should be
submitted by facsimile to Professional
and Scientific Associates (PSA), the
logistical support contractor for the
meeting, at fax number (703) 234–1701.
Registration can also be completed
electronically at http://www.psava.com/
dot/acot2007/. Individuals without
access to the Internet who wish to
register may call Sowjanya Kotakonda
with PSA at (703) 234–1737. Individuals
who plan to attend the meeting and
need special assistance, such as sign
jlentini on PROD1PC65 with NOTICES
language interpretation or other
reasonable accommodations, should
notify the ACOT Executive Secretary,
Remy Aronoff, in advance of the
meeting. Mr. Aronoff may be reached by
VerDate Aug<31>2005 17:37 Apr 04, 2007 Jkt 211001
telephone at 301–443–3264, e-mail:
Remy.Aronoff@hrsa.hhs.gov or in
writing at the address provided below.
Management and support services for
ACOT functions are provided by the
Division of Transplantation, Healthcare
Systems Bureau, Health Resources and
Services Administration, 5600 Fishers
Lane, Parklawn Building, Room 12C–06,
Rockville, Maryland 20857; telephone
number 301–443–7577.
After the presentations and ACOT
discussions, members of the public will
have an opportunity to provide
comments. Because of the Committee’s
full agenda and the timeframe in which
to cover the agenda topics, public
comment will be limited. All public
comments will be included in the
record of the ACOT meeting.
Dated: March 29, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–6365 Filed 4–4–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Training in
Primary Care Medicine and Dentistry;
Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: Advisory Committee on Training in
Primary Care Medicine and Dentistry.
Date and Time: May 17, 2007, 8:30 a.m.–
4:30 p.m. and May 18, 2007, 8:00 a.m.–2:00
p.m.,
Place: Hilton Washington, DC/Rockville
Executive Meeting Center, 1750 Rockville
Pike, Rockville, Maryland 20852.
Status: The meeting will be open to the
public.
Purpose: The Advisory Committee
provides advice and recommendations on a
broad range of issues dealing with programs
and activities authorized under section 747
of the Public Health Service Act as amended
by The Health Professions Education
Partnership Act of 1998, Public Law 105–
392. At this meeting the Advisory Committee
will begin work on its seventh report which
will be submitted to Congress and to the
Secretary of the Department of Health and
Human Services.
Agenda: The meeting on Thursday, May 17
will begin with opening comments from the
Chair of the Advisory Committee and
introductory remarks from senior
management of the Health Resources and
Services Administration. A plenary session
will follow in which the Advisory Committee
will select a topic for its seventh report and
develop a plan for completion of the report.
PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM
In both small groups and in the plenary
session, the Advisory Committee will
determine recommendations for the report.
An opportunity will be provided for public
comment.
On Friday, May 18 the Advisory
Committee will continue work on the
seventh report. The Advisory Committee will
plan next steps in the report preparation
process. An opportunity will be provided for
public comment.
For Further Information Contact: Anyone
interested in obtaining a roster of members or
other relevant information should write or
contact Jerilyn K. Glass, M.D., Ph.D., Division
of Medicine and Dentistry, Bureau of Health
Professions, Health Resources and Services
Administration, Room 9A–27, Parklawn
Building, 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 443–6785.
The Web address for information on the
Advisory Committee is http://bhpr.hrsa.gov/
medicine-dentistry/actpcmd.
Dated: March 27, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review
and Coordination.
[FR Doc. E7–6368 Filed 4–4–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Availability of Draft Policy
Document for Comment
AGENCY: Health Resources and Services
Administration (HRSA), HHS.
ACTION: This is a Notice of Availability
and request for comments on a draft
Agency Guidance (‘‘Policy Information
Notice’’ (PIN)) to clarify the scope of
Federal Torts Claims Act (FTCA)
coverage for FTCA-deemed Health
Center Program grantees during an
emergency. The PIN, ‘‘Federal Tort
Claims Act Coverage for Health Center
Program Grantees Responding to
Emergencies’’ (‘‘FTCA PIN’’) is available
on the Internet at http://bphc.hrsa.gov.
DATES: Comments must be received by
May 31, 2007.
ADDRESSES: Please send your comments
to the following e-mail address:
DPDgeneral@hrsa.gov.
SUMMARY: HRSA believes that
community input is valuable to the
development of policies and policy
documents related to the
implementation of primary health care
programs, including the Health Center
Program. Therefore, we are requesting
comments on the PIN referenced above.
After review and consideration of all
comments received, the PIN may be
amended to incorporate certain
05APN1
 Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices
recommendations from the public. Once
the PIN is finalized, it will be made
available on HRSA’s Web site, along
with the Agency’s ‘‘Response to Public
Comments.’’ That document will
summarize the major comments
received and describe the Agency’s
response, including any corresponding
changes made to the PIN. Where
comments do not result in a revision to
the PIN, explanations will be provided.
Background
HRSA administers the Health Center
Program, which supports more than
3,800 health care delivery sites,
including community health centers,
migrant health centers, health care for
the homeless centers, and public
housing primary care centers. Health
centers serve clients that are primarily
low-income and minorities, and deliver
preventive and primary care services to
patients regardless of their ability to
pay. Charges for health care services are
set according to income.
FTCA medical malpractice coverage
for Health Center Program grantees was
initially legislated through the Federally
Supported Health Centers Assistance
Act (FSHCAA) of 1992. The FSHCAA of
1995 clarified the 1992 Act and
eliminated its sunset provision, making
the program permanent. FSCHAA
authorizes Health Center Program
grantees (and their officers, directors,
employees, and certain contractors) to
be deemed as Federal employees for the
purpose of medical malpractice
protection. As Federal employees, these
organizations and individuals are
immune from medical malpractice suits
for actions within the scope of their
project and employment. In the event
that a medical malpractice lawsuit is
filed against a deemed entity or covered
physician acting within the scope of
his/her employment in grant-related
activities, the United States is
substituted for the deemed entity and
the covered employee.
HRSA recognizes that, during an
emergency, FTCA-deemed health
centers are likely to participate in
medical response efforts. HRSA has
received numerous requests for
clarification regarding the scope of
FTCA coverage during emergencies. The
purpose of the FTCA PIN is to respond
to these requests for clarification and to
address frequently asked FTCA
questions.
jlentini on PROD1PC65 with NOTICES
FOR FURTHER INFORMATION CONTACT: For
questions regarding this notice, please
contact Shannon Dunne Faltens at 301–
594–4060.
VerDate Aug<31>2005 17:37 Apr 04, 2007 Jkt 211001
Dated: March 29, 2007.
Elizabeth M. Duke,
Administrator.
[FR Doc. E7–6366 Filed 4–4–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
Public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Molecular
Oncology P01 Special Emphasis Panel.
Date: June 4–5, 2007.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Michael B. Small, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd., Room 8127, Bethesda, MD
20892–8328, 301–402–0996,
smallm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cellular
and Tissue Biology (SEP).
Date: June 4–5, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Conference
Center, 5701 Marinelli Road, Bethesda, MD
20852.
Contact Person: Shakeel Ahmad, PhD,
Scientific Review Administrator, Research
Projects Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8137,
MSC 8328, Bethesda, MD 20892, (301) 594–
0114, ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Prevention,
Control and Population Science.
Date: June 7, 2007.
Time: 8 a.m. to 4 p.m.
PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM
16799
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Wlodek Lopaczynski, MD,
PhD, Scientific Review Administrator,
Research Programs Review Branch, Division
of Extramural Activities, National Cancer
Institute, 6116 Executive Blvd. Room 8131,
Bethesda, MD 20892, 301–593–1402,
lopacw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 27, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1694 Filed 4–4–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
Public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
A—Cancer Centers.
Date: April 24, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Gail J. Bryant, MD.,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8107,
MSC 8328, Bethesda, MD 20892–8328, (301)
402–0801, gb30t@nih.gov.
05APN1